FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms
Steady2 outlets reported this in 2 reports over 2 days
Wed, 5 August 2026Mon, 17 August 2026
What it is about
Division Of PsychiatryDrug Enforcement AgencyHuman ServicesUnited StatesDrug AdministrationTyler ChapmanMount EverestLucia Graphus AlamyBarry LubarskyEmmanuel MignotLaguna Design Science Photo LibraryUniversity Of TennesseeAlkermesTakeda Pharmaceuticals AmericaStanford UniversityIrelandDublin, Dublin, IrelandMassachusetts, United StatesStanford University, California, United StatesCambridge, Cambridgeshire, United Kingdom
Who published it, and when
original reportfirst to report
fda.gov
nature.com
5 Aug, 20:45over 11 days17 Aug, 00:00
How it spread - 2 original reports
Wed, 5 August 2026
1 report- fda.gov20:45first to report
The FDA approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults.
Mon, 17 August 2026
1 report- nature.com00:00
The drug, called Orzeyful, takes aim at the root cause of the sleep disorder rather than at its symptoms.